abstract |
Provided is a humanized monoclonal antibody or antibody fragment thereof that is effective in the treatment of arteriosclerosis and metabolic syndrome and selectively inhibits the activity of vascular endothelial lipase, and contains the humanized monoclonal antibody or antibody fragment thereof as an active ingredient pharmaceutical composition. |